Actively Recruiting

Phase 3
Age: 65Years +
All Genders
Healthy Volunteers
NCT03848312

Preventing Alzheimer's With Cognitive Training

Led by University of South Florida · Updated on 2024-09-26

7600

Participants Needed

7

Research Sites

362 weeks

Total Duration

On this page

Sponsors

U

University of South Florida

Lead Sponsor

N

National Institute on Aging (NIA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Dementia is the most expensive medical condition in the US and increases in prevalence with age. More than 5 million Americans have Alzheimer's disease, the most common form of dementia. Mild cognitive impairment is a transitional stage between normal cognitive aging and Alzheimer's disease or another type of dementia, and is indicative of higher risk for dementia. In addition to the obvious health and quality-of-life ramifications of dementia, there are high direct (e.g., subsidizing residential care needs) and indirect (e.g., lost productivity of family caregivers) economic costs. Implementing interventions to prevent MCI and dementia among older adults is of critical importance to health and maintained quality-of-life for millions of Americans. Recent data analyses from the Advanced Cognitive Training in Vital Elderly study (ACTIVE) indicate that a specific cognitive intervention, speed of processing training (SPT), significantly delays the incidence of cognitive impairment across 10 years. The primary contribution of the proposed research will be the determination of whether this cognitive training technique successfully delays the onset of clinically defined MCI or dementia across three years.

CONDITIONS

Official Title

Preventing Alzheimer's With Cognitive Training

Who Can Participate

Age: 65Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Be age 65 or older at time of consent
  • Ability to speak and understand English or Spanish
  • Adequate sensorimotor ability to perform computer exercises
  • Adequate vision to read a computer screen at typical distance
  • Adequate hearing to understand conversational speech
  • Adequate motor skills to use a computer screen or mouse
  • No evidence of mild cognitive impairment or dementia (Montreal Cognitive Assessment score 6 26)
  • Adequate mental health without interfering mental illness
  • Willingness to complete all study activities
  • Ability to understand and comply with study procedures for the study duration
Not Eligible

You will not qualify if you...

  • Currently enrolled in another cognition-related clinical or treatment study
  • Previous participation in a cognitive training study
  • Vision, hearing, or motor problems interfering with study exercises
  • Diagnosis of mild cognitive impairment, dementia, stroke, traumatic brain injury, brain tumor, or neurological disorder affecting cognition
  • Unstable medical conditions likely to cause cognitive or functional decline
  • Use of dementia medications such as Namenda, Memantine, Donepezil, Aricept, and others
  • Completed 10+ hours of computerized cognitive training in last 5 years
  • Severe depressive symptoms (Geriatric Depression Scale score 6 5)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

University of Florida

Gainesville, Florida, United States, 32611

Active, Not Recruiting

2

University of Florida

Jacksonville, Florida, United States, 32209

Active, Not Recruiting

3

University of North Florida

Jacksonville, Florida, United States, 32224

Terminated

4

The Roskamp Institute

Sarasota, Florida, United States, 34243

Actively Recruiting

5

University of South Florida

Tampa, Florida, United States, 33620

Actively Recruiting

6

Duke Health

Durham, North Carolina, United States, 27705

Actively Recruiting

7

Clemson University Institute for Engaged Aging

Seneca, South Carolina, United States, 29672

Actively Recruiting

Loading map...

Research Team

J

Jennifer L O'Brien, PhD

CONTACT

J

Jennifer Lister, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here